(Q37679954)

21 August 2017

1 reference

title

Liposomal cancer therapy: exploiting tumor characteristics (English)

1 reference

21 August 2017

Thomas Kaasgaard

1

1 reference

21 August 2017

Thomas L Andresen

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Drug Delivery

21 August 2017

published in

1 reference

21 August 2017

volume

7

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

225-243

1 reference

21 August 2017

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Peptide and protein drug delivery to and into tumors: challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

siRNA delivery systems for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

21 January 2018

Liposome opsonization

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Liposomes for the sustained drug release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Poly(Hpma)-coated liposomes demonstrate prolonged circulation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

A Novel Family ofl-Amino Acid-Based Biodegradable Polymer−Lipid Conjugates for the Development of Long-Circulating Liposomes with Effective Drug-Targeting Capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Measurements of interbilayer forces and protein adsorption on uncharged lipid bilayers displaying poly(ethylene glycol) chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Screening effect of PEG on avidin binding to liposome surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Ligand-targeted liposomes for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Ligand-targeted liposomal anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tumor-vascular interactions and tumor dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Cellular abnormalities of blood vessels as targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

The neovasculature homing motif NGR: more than meets the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Selective targeting of cancer cells using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Ultrasound triggered release of cisplatin from liposomes in murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Prodrug strategies in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Phospholipase A2 as targets for anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Activation of interfacial enzymes at membrane surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Matrix metalloproteinases as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

"Uncorking" of liposomes by matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Release of liposomal contents by cell-secreted matrix metalloproteinase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Endocytosis and intracellular fate of liposomes using pyranine as a probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Sheddable coatings for long-circulating nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Bicarbonate increases tumor pH and inhibits spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Enzyme and Proton-Activated Prodrugs for a Selective Cancer Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Current status of pH-sensitive liposomes in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Cell-penetrating peptides for drug delivery across membrane barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Immunoliposomes for the targeted delivery of antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903427940

10.1517/17425240903427940

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference